Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

New review highlights ethnic inequalities in children’s food allergy care 21st May 2026

A new international review has highlighted important inequalities in the prevalence, management, and outcomes of IgE-mediated food allergies among children from different ethnic backgrounds. The scoping review, published in the World Allergy Organization Journal, analysed 37 studies from high-income countries
[…]

Read more
A Tribute to Jenson 30th April 2026

Today, we’re remembering Jenson Joseph. Losing him so young, aged just 25 on 30 April 2024, was the result of a rare anaphylactic reaction as he lay sleeping. Diagnosed with a peanut and almond allergy at the age of 21,
[…]

Read more
Why accessible colour matters to allergy safety in schools 28th April 2026

By Marie Difolco, author of ‘Supporting Colour Blindness in Education and Beyond‘ When people think about allergy safety in schools, they rightly think about training, Individual Healthcare Plans, clear labelling and access to adrenaline devices. What they do not usually
[…]

Read more

News Type:

First Oral Immunotherapy Drug ‘Palforzia’ gets FDA Approval 3rd February 2020

The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has

Read more
Clinicians & Charities Call For Urgent Action to Keep Food Allergic Children Safe in School 29th January 2020

An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of children with medical conditions in schools, and highlights

Read more
Positive results in peanut allergy treatment trials 27th January 2020

Biopharmaceutical company DBV Technologies has announced positive results from its Viaskin® Peanut trial into reducing the risk of allergic reaction in children aged 4 to 11. Viaskin is a patch applied directly to the surface of the skin and contains

Read more
Update from Sacla regarding pesto recall 20th January 2020

The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one priority. In December, when we became aware that cashew

Read more
Statement Regarding the Inquest of Shante Turay-Thomas 13th January 2020

The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and the Prevention of Future Deaths report. The Anaphylaxis Campaign would like to extend our deepest condolences to the family of Shante,

Read more
Statement regarding the death of Ken Matthews 6th January 2020

The Anaphylaxis Campaign is saddened to learn of the death of Ken Matthews, 84,  who died at Wrexham Maelor Hospital on 2 June 2019. Consultant pathologist Dr Huyen Abdel Salam told the inquest that Mr Matthews died of an allergic

Read more
Prosecution case: Hertfordshire restaurant fined after customer suffered severe allergic reaction 16th December 2019

The Artichoke, Croxley Green, has been fined £23,000 after being prosecuted by Hertfordshire Trading Standards when one of its customers became seriously ill. Hertfordshire County Council said KOB (The Artichoke) Ltd pleaded guilty to offences under the Food Safety Act

Read more
EAT Study shows early exposure to allergens could stop allergies developing 6th December 2019

New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy

Read more
EAT Study 1st December 2019

New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy to those foods. 

Read more